Solventum Corp. (SOLV) stock news · P/E 10, rev $8.32B
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
This SOLV news page leads with what Solventum Corp. filed — not a scraped headline mill.
No cached 8-K sentence for SOLV yet. We will not pad this page with generic market recap.
Latest reported SOLV revenue for 2025-12-31 was $8.32B. Net income was $1.56B. Revenue was up 0.9% from 2024-12-31 to 2025-12-31. SOLV currently screens at market cap $12.91B and trailing P/E 10.5.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SOLV stock page; for the tape open the quote page.
SOLV stock news FAQ
What are SOLV's latest revenue and net income?
Latest cached Solventum Corp. (SOLV) revenue for Dec 31, 2025 was $8.32B. Net income was $1.56B. Statements: https://lician.com/financials/solv
How did SOLV revenue change from the prior cached period?
Cached Solventum Corp. (SOLV) revenue was up 0.9% from $8.25B (Dec 31, 2024) to $8.32B (Dec 31, 2025). Statements: https://lician.com/financials/solv
What is SOLV's P/E ratio?
Solventum Corp. (SOLV) trailing P/E is 10.5 on the latest cached fundamentals snapshot.
What is SOLV's market cap?
Solventum Corp. (SOLV) market cap is $12.91B on the latest cached fundamentals snapshot.
What kind of company is SOLV?
Solventum Corp. (SOLV) is a medical instruments & supplies company listed on NYSE.
Where is SOLV stock news listed?
Cached stock news for Solventum Corp. (SOLV) is listed at https://lician.com/news/solv. Filings: https://lician.com/sec/solv
Not investment advice.